- Home
- ENTA vs AZ Comparison
ENTA vs AZ Comparison
Compare ENTA & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENTA | AZ |
|---|---|---|
| Founded | 1995 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.6M | 321.2M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ENTA | AZ |
|---|---|---|
| Price | $15.22 | $7.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $20.40 | $15.00 |
| AVG Volume (30 Days) | 123.3K | ★ 339.8K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,814,000.00 | N/A |
| Revenue This Year | $7.76 | $532.60 |
| Revenue Next Year | N/A | $178.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.48 | N/A |
| 52 Week Low | $5.55 | $5.00 |
| 52 Week High | $17.15 | $12.36 |
Technical Indicators
Market Signals| Indicator | ENTA | AZ |
|---|---|---|
| Relative Strength Index (RSI) | 67.77 | 47.59 |
| Support Level | $12.91 | $6.91 |
| Resistance Level | $15.37 | $7.47 |
| Average True Range (ATR) | 0.76 | 0.49 |
| MACD | 0.16 | -0.12 |
| Stochastic Oscillator | 81.47 | 29.97 |
Price Performance
Historical ComparisonAbout ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.